HHI will leverage a two-year distribution deal with Turkken, founded by Birtan Erkut, who is a parent of a child with Autistic Spectrum Disorder, to supply its Halal-certified medicinal cannabis products, increasing therapeutic cannabis access to Muslim and other patients globally.
The ground-breaking deal tops off a busy year for the Australian company as it continues to rapidly expand its global footprint as the demand for a trusted supply of medicinal cannabis products grows.
“This medication has been life-changing for my son and our family”, Birt Erkut said.
“It provides doctors, patients and families an alternative treatment pathway which does not have the side effects of opioid medicines, and now the Muslim community can access this medicine with full confidence in its origins”.
HHI said the deal will grant access to the world’s third-largest legal medicinal cannabis market and features a sizeable Muslim population.
“More and more countries are recognising the benefits of medicinal cannabis, with interest growing from emerging markets such as Asia and the Middle East as legalisation extends globally,” HHI chief executive David Attwood said.
Health House will continue to work with key suppliers to deliver high-quality medicinal cannabis products to the global market.
HHI Australian Stock Exchange-listed price has risen 2.63 per cent today, currently trading at 7.8c (1:04 pm UTC+8 hours)